MedTrace Logo

Adult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort Study

NCT04665674 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-12-17

No results posted yet for this study

Summary

The long-term outcomes of adult patients with pulmonary Langerhans cell histiocytosis (PLCH), particularly survival, is largely unknown. This is the first prospective study in the field evaluating the long-term outcomes of PLCH patients. This french countrywide registry-based study included a large cohort of PLCH patients followed for a sufficiently long period to address risk factors of long-term outcomes of PLCH patients.

Conditions

  • Histiocytosis
  • Histiocytosis, Langerhans-Cell
  • Histiocytosis Pulmonary

Interventions

OTHER

Standard of care

Standard of car of pulmonary Langerhans cell histiocytosis (PLCH)

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-01
Primary Completion
2034-12-31
Completion
2035-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04665674 on ClinicalTrials.gov